RERG gene expression is stimulated by both estrogen receptor (ER) α [29] and ERβ1 [31, 32], and it has been reported as a marker for ERα-positive luminal-like breast cancer and is associated with better clinical outcomes [33] or a favorable response to adjuvant tamoxifen treatment [34]. This evidence concerns the gene ESR1 and breast carcinoma.